Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BCM2-Body Composition Monitor

K-Number: K250634 · 2025-11-24

Decision Date2025-11-24
Product CodeDSB
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

BCM2-Body Composition Monitor is a medical device manufactured by Fresenius Medical Care Renal Therapies Group, LLC. It received FDA 510(k) clearance on 2025-11-24 under approval number K250634. The device is classified under product code DSB. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BCM2-Body Composition Monitor?

BCM2-Body Composition Monitor is a medical device that received FDA 510(k) clearance on 2025-11-24. It is manufactured by Fresenius Medical Care Renal Therapies Group, LLC. The 510(k) number is K250634.

When was BCM2-Body Composition Monitor approved by the FDA?

BCM2-Body Composition Monitor received FDA 510(k) clearance on 2025-11-24, under approval number K250634.

What company makes BCM2-Body Composition Monitor?

BCM2-Body Composition Monitor is manufactured by Fresenius Medical Care Renal Therapies Group, LLC.

What is the FDA product code for BCM2-Body Composition Monitor?

The FDA product code for BCM2-Body Composition Monitor is DSB.

Related Clinical Trials

Other Devices by Fresenius Medical Care Renal Therapies Group, LLC

View all 47 devices →

Related Devices (Code: DSB)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.